Kimberly Chong

Array ( [id] => 5242866 [patent_doc_number] => 20070021361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Methods and materials for modulating trpm2' [patent_app_type] => utility [patent_app_number] => 10/537741 [patent_app_country] => US [patent_app_date] => 2003-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11139 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021361.pdf [firstpage_image] =>[orig_patent_app_number] => 10537741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966432 [patent_doc_number] => 20050233329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Inhibition of gene expression using duplex forming oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/727780 [patent_app_country] => US [patent_app_date] => 2003-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 46537 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233329.pdf [firstpage_image] =>[orig_patent_app_number] => 10727780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7237785 [patent_doc_number] => 20050080031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Nucleic acid treatment of diseases or conditions related to levels of Ras, HER2 and HIV' [patent_app_type] => utility [patent_app_number] => 10/724270 [patent_app_country] => US [patent_app_date] => 2003-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 68280 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080031.pdf [firstpage_image] =>[orig_patent_app_number] => 10724270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7190282 [patent_doc_number] => 20040204377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Delivery of siRNAs' [patent_app_type] => new [patent_app_number] => 10/722176 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10539 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204377.pdf [firstpage_image] =>[orig_patent_app_number] => 10722176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649677 [patent_doc_number] => 20060135412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Methods for the treatment of alzheimers disease and compositions therefore' [patent_app_type] => utility [patent_app_number] => 10/535385 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14615 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135412.pdf [firstpage_image] =>[orig_patent_app_number] => 10535385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7295904 [patent_doc_number] => 20040214198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Allele-targeted RNA interference' [patent_app_type] => new [patent_app_number] => 10/715229 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13857 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214198.pdf [firstpage_image] =>[orig_patent_app_number] => 10715229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760693 [patent_doc_number] => 20060211638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Exon 1 ss of pdgf alpha gene and utilization thereof' [patent_app_type] => utility [patent_app_number] => 10/534836 [patent_app_country] => US [patent_app_date] => 2003-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5830 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211638.pdf [firstpage_image] =>[orig_patent_app_number] => 10534836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7070087 [patent_doc_number] => 20050245472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Engineered rnai adenovirus silencing expression (erase) of dna reair proteins' [patent_app_type] => utility [patent_app_number] => 10/534010 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 15413 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245472.pdf [firstpage_image] =>[orig_patent_app_number] => 10534010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 536989 [patent_doc_number] => 07176303 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-13 [patent_title] => 'Modulation of STAT5 expression' [patent_app_type] => utility [patent_app_number] => 10/704263 [patent_app_country] => US [patent_app_date] => 2003-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24407 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/176/07176303.pdf [firstpage_image] =>[orig_patent_app_number] => 10704263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169120 [patent_doc_number] => 20040077579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Pharmaceutical compositions for the prevention and treatment of atherosclerosis and restenosis after PTCA' [patent_app_type] => new [patent_app_number] => 10/703783 [patent_app_country] => US [patent_app_date] => 2003-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7325 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077579.pdf [firstpage_image] =>[orig_patent_app_number] => 10703783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7149606 [patent_doc_number] => 20040171031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation' [patent_app_type] => new [patent_app_number] => 10/701236 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33457 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171031.pdf [firstpage_image] =>[orig_patent_app_number] => 10701236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7149598 [patent_doc_number] => 20040171028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Phosphorous-linked oligomeric compounds and their use in gene modulation' [patent_app_type] => new [patent_app_number] => 10/700688 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35241 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171028.pdf [firstpage_image] =>[orig_patent_app_number] => 10700688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 986325 [patent_doc_number] => 06920655 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-26 [patent_title] => 'Multi-purpose mat' [patent_app_type] => utility [patent_app_number] => 10/698698 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 10 [patent_no_of_words] => 3343 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/920/06920655.pdf [firstpage_image] =>[orig_patent_app_number] => 10698698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470455 [patent_doc_number] => 20040121376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Antisense modulation of interleukin-5 signal transduction' [patent_app_type] => new [patent_app_number] => 10/679532 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26710 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121376.pdf [firstpage_image] =>[orig_patent_app_number] => 10679532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7347901 [patent_doc_number] => 20040248145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Methods of using mammalian RNase H and compositions thereof' [patent_app_type] => new [patent_app_number] => 10/679761 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 28854 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248145.pdf [firstpage_image] =>[orig_patent_app_number] => 10679761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7088505 [patent_doc_number] => 20050008617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Compositions and methods for delivery of short interfering RNA and short hairpin RNA' [patent_app_type] => utility [patent_app_number] => 10/674087 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 41425 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20050008617.pdf [firstpage_image] =>[orig_patent_app_number] => 10674087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7025521 [patent_doc_number] => 20050019915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Antisense modulation of superoxide dismutase 1, soluble expression' [patent_app_type] => utility [patent_app_number] => 10/672866 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 37212 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019915.pdf [firstpage_image] =>[orig_patent_app_number] => 10672866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026571 [patent_doc_number] => 20050020521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'In vivo gene silencing by chemically modified and stable siRNA' [patent_app_type] => utility [patent_app_number] => 10/672069 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 49995 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 43 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020521.pdf [firstpage_image] =>[orig_patent_app_number] => 10672069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 472731 [patent_doc_number] => 07229976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-12 [patent_title] => 'Modulation of forkhead box O1A expression' [patent_app_type] => utility [patent_app_number] => 10/671074 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 37607 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/229/07229976.pdf [firstpage_image] =>[orig_patent_app_number] => 10671074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905524 [patent_doc_number] => 20050100919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Nucleic acid-based detection' [patent_app_type] => utility [patent_app_number] => 10/668507 [patent_app_country] => US [patent_app_date] => 2003-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15433 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100919.pdf [firstpage_image] =>[orig_patent_app_number] => 10668507 [rel_patent_id] =>[rel_patent_doc_number] =>)